| Primary |
| Urinary Tract Infection |
34.8% |
| Cystitis |
21.7% |
| Hypertension |
6.1% |
| Septic Shock |
5.2% |
| Mental Disorder |
4.3% |
| Contraception |
2.6% |
| Diabetes Mellitus |
2.6% |
| Ischaemic Cardiomyopathy |
2.6% |
| Major Depression |
2.6% |
| Sinusitis |
2.6% |
| Asthma |
1.7% |
| Cardiomyopathy |
1.7% |
| Cerebrovascular Accident |
1.7% |
| Pain |
1.7% |
| Pain Prophylaxis |
1.7% |
| Renal Colic |
1.7% |
| Spinal Pain |
1.7% |
| Arthralgia |
0.9% |
| Cardiac Disorder |
0.9% |
| Convulsion |
0.9% |
|
| Vomiting |
10.3% |
| Pruritus |
7.7% |
| Skin Ulcer |
7.7% |
| Arrhythmia |
5.1% |
| Asthenia |
5.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.1% |
| Headache |
5.1% |
| Hepatic Failure |
5.1% |
| Hypersensitivity |
5.1% |
| Off Label Use |
5.1% |
| Palpitations |
5.1% |
| Pruritus Generalised |
5.1% |
| Rash Maculo-papular |
5.1% |
| Sepsis |
5.1% |
| Urticaria |
5.1% |
| Blood Sodium Decreased |
2.6% |
| Dermatitis Allergic |
2.6% |
| Drug Ineffective |
2.6% |
| Fixed Eruption |
2.6% |
| Genital Pain |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
23.7% |
| Pyrexia |
12.6% |
| Meningitis Enterococcal |
8.7% |
| Drug Use For Unknown Indication |
7.7% |
| Foetal Exposure During Pregnancy |
4.8% |
| Nasopharyngitis |
3.9% |
| Pneumonia |
3.9% |
| Spondylitis |
3.9% |
| Urinary Tract Infection |
3.9% |
| Pseudomonas Infection |
3.4% |
| Hidradenitis |
2.9% |
| Sinusitis |
2.9% |
| Staphylococcal Sepsis |
2.9% |
| Clostridium Difficile Infection |
2.4% |
| Pain |
2.4% |
| Prophylaxis |
2.4% |
| Bacterial Infection |
1.9% |
| Cough |
1.9% |
| Diagnostic Procedure |
1.9% |
| Osteitis |
1.9% |
|
| Agranulocytosis |
10.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
10.5% |
| International Normalised Ratio Increased |
10.5% |
| Colitis Ulcerative |
8.8% |
| Stevens-johnson Syndrome |
8.8% |
| Acute Generalised Exanthematous Pustulosis |
5.3% |
| Condition Aggravated |
5.3% |
| Rash Maculo-papular |
5.3% |
| Septic Shock |
5.3% |
| Transaminases Increased |
5.3% |
| Autism |
3.5% |
| Infusion Related Reaction |
3.5% |
| Roseolovirus Test Positive |
3.5% |
| Toxic Skin Eruption |
3.5% |
| Anaphylactic Reaction |
1.8% |
| C-reactive Protein Increased |
1.8% |
| Cerebral Thrombosis |
1.8% |
| Congenital Hydronephrosis |
1.8% |
| Drug Exposure During Pregnancy |
1.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
1.8% |
|
| Concomitant |
| Diffuse Panbronchiolitis |
15.1% |
| Drug Use For Unknown Indication |
13.5% |
| Product Used For Unknown Indication |
13.0% |
| Hiv Infection |
12.1% |
| Sepsis |
6.0% |
| Septic Shock |
4.2% |
| Staphylococcal Bacteraemia |
3.7% |
| Ulcerative Keratitis |
3.7% |
| Cystic Fibrosis Lung |
3.5% |
| Immunosuppression |
3.0% |
| Infection |
2.8% |
| Pseudomonas Infection |
2.6% |
| Bronchitis |
2.3% |
| Hypertension |
2.3% |
| Brain Abscess |
2.1% |
| Medical Diet |
2.1% |
| Pyrexia |
2.1% |
| Urinary Tract Infection |
2.1% |
| Arthritis Infective |
1.9% |
| Diarrhoea |
1.9% |
|
| Renal Failure |
12.5% |
| Hepatorenal Syndrome |
7.5% |
| Staphylococcal Bacteraemia |
6.3% |
| Thrombocytopenia |
6.3% |
| Hepatic Neoplasm Malignant |
5.0% |
| Osteomyelitis |
5.0% |
| Renal Failure Acute |
5.0% |
| Sepsis |
5.0% |
| Stereotypy |
5.0% |
| Transaminases Increased |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Acute Generalised Exanthematous Pustulosis |
3.8% |
| Autism |
3.8% |
| Diffuse Panbronchiolitis |
3.8% |
| Drug Ineffective |
3.8% |
| Multi-organ Failure |
3.8% |
| Pseudomembranous Colitis |
3.8% |
| Tremor |
3.8% |
| Ulcerative Keratitis |
3.8% |
| Cardio-respiratory Arrest |
2.5% |
|
| Interacting |
| Bronchitis Chronic |
12.9% |
| Gastritis |
12.9% |
| Pneumonia |
12.9% |
| Hepatitis C |
9.7% |
| Arrhythmia |
6.5% |
| Atrial Fibrillation |
6.5% |
| Cardiac Failure Chronic |
6.5% |
| Oedema |
6.5% |
| Thrombosis Prophylaxis |
6.5% |
| Anaemia |
3.2% |
| Gastritis Prophylaxis |
3.2% |
| Laxative Supportive Care |
3.2% |
| Neutropenia |
3.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.2% |
| Urinary Tract Infection |
3.2% |
|
| Pneumonia Aspiration |
66.7% |
| Hyponatraemia |
33.3% |
|
